Hemochron Whole Blood Coagulation System QCACTRecalls & reported problems
Accriva Diagnostics Holdings, Inc. · ACT Whole Blood Quality Control 40/box · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10711234102206), received between Mar 8, 2018 and Mar 8, 2018 — classified as 1 malfunction.
The most frequently reported specific device problem is “Device Handling Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Handling Problem1
Patient problems
- Laceration(s)1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 8, 2018Device Handling Problem; Device Handling Problem
OCCUPATIONAL HEALTH NURSE REPORTED A NEEDLE STICK INJURY SUSTAINED BY AN END USER PERFORMING QC TESTING WITH A HEMOCHRON 801 ACT TUBE COAGULATION SYSTEM. WHILE WITHDRAWING THE QC MATERIAL FROM THE QCACT VIAL, THE NEEDLE SLIPPED AND PUNCTURED THE END USER'S MIDDLE FINGER ON HER LEFT HAND. THE END USER SQUEEZED THE INVOLVED BODY PART AND WASHED IT WITH SOAP AND WATER THREE TIMES. THE END USER ALSO APPLIED PROVIDONE IODINE. NO ADDITIONAL MANAGEMENT WAS ADMINISTERED BY THE OCCUPATIONAL HEALTH NURSE.
Patient problems: Laceration(s)
MAUDE report 7325813 ↗
Other Plasma, Coagulation Control devices
- STA® - System Control N + P 00678Diagnostica Stago · PLASMA, COAGULATION CONTROL1 recall0 reports
- directCHECK ACT-LR Whole Blood Control, Level 2 000DCGLR-2Accriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control1 recall0 reports
- 5-PLASMA Bivalirudin Control 5D-449055-Diagnostics Ltd · Plasma, Coagulation Control1 recall0 reports
- BIOPHEN UFH Control Plasma 223101Hyphen Biomed · Plasma, Coagulation Control1 recall0 reports
- directCHECK Whole Blood Controls DCJLR-AAccriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control5 reports
- directCHECK Whole Blood Controls DCJLR-NAccriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control2 reports
- Control Plasma N 10446235Siemens Healthcare Diagnostics Products GmbH · PLASMA, COAGULATION CONTROL1 report
- directCHECK Whole Blood Controls DCJACT-AAccriva Diagnostics Holdings, Inc. · Plasma, Coagulation Control1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page